Citation Impact
Citing Papers
Human Papillomavirus 16 E7 Oncoprotein Attenuates DNA Damage Checkpoint Control by Increasing the Proteolytic Turnover of Claspin
2009
Rhizobium induces DNA damage in Caenorhabditis elegans intestinal cells
2019 StandoutNobel
A Genetic Variant of Aurora Kinase A Promotes Genomic Instability Leading to Highly Malignant Skin Tumors
2009
Development and Implementation of a Miniaturized High-Throughput Time-Resolved Fluorescence Energy Transfer Assay to Identify Small Molecule Inhibitors of Polo-Like Kinase 1
2007
Combination of Chemical Genetics and Phosphoproteomics for Kinase Signaling Analysis Enables Confident Identification of Cellular Downstream Targets
2011
Synthetic lethality: a framework for the development of wiser cancer therapeutics
2009 StandoutNobel
Fluorescent Sensors of Protein Kinases
2012
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
2012 Standout
Ubiquitylation of the amino terminus of Myc by SCFβ-TrCP antagonizes SCFFbw7-mediated turnover
2010
MYC on the Path to Cancer
2012 Standout
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Animal Models of Colitis‐Associated Carcinogenesis
2011
Using Ligand‐Mapping Simulations to Design a Ligand Selectively Targeting a Cryptic Surface Pocket of Polo‐Like Kinase 1
2012
Molecular Dynamics Simulation for All
2018 Standout
Polo on the Rise—from Mitotic Entry to Cytokinesis with Plk1
2008
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
2009
The Chromosomal Instability Pathway in Colon Cancer
2010
Checkpoint control and cancer
2011
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia
2014
Mitotic DNA Damage Response: At the Crossroads of Structural and Numerical Cancer Chromosome Instabilities
2017
Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)
2010
Pyroptosis: A new frontier in cancer
2019 Standout
Cyclin B2 and p53 control proper timing of centrosome separation
2014
Plx1 is required for chromosomal DNA replication under stressful conditions
2008
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Pattern formation in centrosome assembly
2012
Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle
2014
Slaying RAS with a synthetic lethal weapon
2010 StandoutNobel
A Fluorogenic Aryl Fluorosulfate for Intraorganellar Transthyretin Imaging in Living Cells and in Caenorhabditis elegans
2015 StandoutNobel
Liquid-Liquid Phase Separation in Biology
2014 Standout
Cancer Genome Landscapes
2013 StandoutScience
Use and Abuse of RNAi to Study Mammalian Gene Function
2012 StandoutScienceNobel
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Works of Dan Lim being referenced
Polo-Like Kinase-1 Controls Aurora A Destruction by Activating APC/C-Cdh1
2009
Peptoid–Peptide Hybrid Ligands Targeting the Polo Box Domain of Polo‐Like Kinase 1
2012
Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel
2011
Proteomic screen defines the Polo‐box domain interactome and identifies Rock2 as a Plk1 substrate
2007
Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery
2008 Nature